Patents by Inventor Paul Palumbo

Paul Palumbo has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20160199361
    Abstract: A method of inducing an anti-retroviral immune response by counter-acting retro-virus induced anti-apoptosis is disclosed. The present invention relates, at least in part, to agents and methods for treating, inhibiting, vaccinating or controlling HIV. In certain non-limiting aspects, it relates to the reduction of viral load in an HIV-1 infected subject, while simultaneously developing immunological responsiveness within the subject toward HIV-1 that continues after the agent is removed or excreted from the subject's body.
    Type: Application
    Filed: August 19, 2014
    Publication date: July 14, 2016
    Inventors: Hartmut M. Hanauske-Abel, Paul Palumbo, Bernadette M. Cracchiolo, Axel R. Hanauske, Michael B. Mathews
  • Publication number: 20120225093
    Abstract: The present invention relates to compositions and methods of treating, inhibiting, or controlling HIV infection.
    Type: Application
    Filed: October 11, 2011
    Publication date: September 6, 2012
    Applicant: UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY
    Inventors: Michael B. Mathews, Hartmut M. Hanauske-Abel, Tsafi Pe'ery, Mainul Hoque, Paul Palumbo, Deepti Saxena, Darlene D'Alliessi-Gandolfi, Myung-Hee Park
  • Publication number: 20120095058
    Abstract: The present invention discloses compounds and pharmaceutical compositions which are highly effective at inhibiting the accumulation of spliced and unspliced viral transcripts and their utilization for viral protein synthesis at cellular ribosomes, and at inhibiting the formation of the hypusine residue in cellular eIF-5A precursor proteins, the cellular cofactors that render spliced and unspliced viral transcripts translatable at the ribosomes of infectled cells. The invention further relates to methods of using such compounds and pharmaceutical compositions therefrom for inhibiting or preventing viral protein synthesis. Such inhibition cause a dose-dependent release from the virally induced arrest of the otherwise genetically preprogrammed apoptosis of virally infected cells, and in consequence, triggers their apoptotic ablation and the eradication of the chronic infection-mediating provirus integrated into their genome.
    Type: Application
    Filed: December 1, 2004
    Publication date: April 19, 2012
    Inventors: H., M. Hanauske-Abel, Paul Palumbo, B., M. Cracchiolo, Myung-Hee Park, Edith Wolff, Axel-Rainer Hanauske, Michael B. Mathews, Deepti Saxena, Mainul Hoque
  • Publication number: 20070100024
    Abstract: The present invention relates to a modified colorant comprising a colorant having attached at least one organic group. Various embodiments of the organic group are disclosed. For each of these embodiments, preferably the organic group has a defined calcium index value. Also disclosed are various uses for these modified colorants, including inkjet ink compositions.
    Type: Application
    Filed: October 31, 2006
    Publication date: May 3, 2007
    Inventors: Feng Gu, James Belmont, Elizabeth Burns, Paul Palumbo, Barry Corden, Yuan Yu, Ervina Halim
  • Publication number: 20070021530
    Abstract: The present invention relates to a method of preparing a pigment composition comprising the steps of combining a polymer and a pigment to form a mixture and heating the mixture to a temperature of between about 70° C. and 250° C. to form the pigment composition. The method may further comprise the step of dispersing the pigment composition in an aqueous medium to form an aqueous pigment dispersion. The pigment compositions and aqueous pigment compositions can be used in an inkjet ink composition, which is also disclosed.
    Type: Application
    Filed: July 21, 2006
    Publication date: January 25, 2007
    Inventor: Paul Palumbo